[PDF][PDF] Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease

S Todo, AJ Demetris, D Van Thiel, L Teperman… - …, 1991 - Wiley Online Library
Fifty‐nine patients with prior hepatitis B virus infection underwent orthotopic liver
transplantation. During the first 2 mo, mortality was not significantly different in the hepatitis B …

IFN‐α subtypes: distinct biological activities in anti‐viral therapy

K Gibbert, JF Schlaak, D Yang… - British journal of …, 2013 - Wiley Online Library
During most viral infections, the immediate host response is characterized by an induction of
type I IFN. These cytokines have various biological activities, including anti‐viral, anti …

Differential regulation of human blood dendritic cell subsets by IFNs

T Ito, R Amakawa, M Inaba, S Ikehara… - The Journal of …, 2001 - journals.aai.org
Based on the relative expression of CD11c and CD1a, we previously identified subsets of
dendritic cells (DCs) or DC precursors in human peripheral blood. A CD1a+/CD11c+ …

Antivirals: past, present and future

E De Clercq - Biochemical pharmacology, 2013 - Elsevier
Vaccination is possible to prevent infections with some viruses: hepatitis B virus (HBV),
varicella-zoster virus (VZV), influenza A and B viruses, Yellow fever virus and poliovirus; but …

Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma

JU GUTTERMAN, GR BLUMENSCHEIN… - Annals of Internal …, 1980 - acpjournals.org
Thirty-eight patients with advanced breast cancer, multiple myeloma, and malignant
lymphoma were treated with partially purified (about 0.1%) leukocyte interferon. Patients …

Survival in chronic hepatitis B: an analysis of 379 patients

JEDI WEISSBERG, LL ANDRES, CI SMITH… - Annals of internal …, 1984 - acpjournals.org
Survival data from 379 patients with chronic hepatitis B were analyzed to determine life
expectancy for the patient from the time of first contact. One hundred twenty-one patients had …

[HTML][HTML] Alpha-interferon treatment in hepatitis B

ASJ Woo, R Kwok, T Ahmed - Annals of translational medicine, 2017 - ncbi.nlm.nih.gov
Pegylated interferon-α (PEG-IFN-α) is a first line option in the treatment of chronic hepatitis
B. Compared with nucleos (t) ide analogues (NAs), therapy with PEG-IFN-α has the …

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

M Altun, A Fandi, O Dupuis, E Cvitkovic… - International Journal of …, 1995 - Elsevier
Undifferentiated carcinoma of the nasopharynx (UCNT) is a particular head and neck
epidermoid lineage tumor related to the Epstein Barr Virus (EBV). It has geographically …

[HTML][HTML] Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines

LO De Serrano, DJ Burkhart - Journal of nanobiotechnology, 2017 - Springer
Vaccinology is one of the most important cornerstones in modern medicine, providing better
quality of life. The human immune system is composed of innate and adaptive immune …

Intrathecal interferon reduces exacerbations of multiple sclerosis

L Jacobs, J O'Malley, A Freeman, R Ekes - Science, 1981 - science.org
Ten patients with multiple sclerosis who were treated with human fibroblast interferon (IFN-
B) for 6 months showed a significant reduction in their exacerbation rates compared with …